Sign up to save your podcasts
Or
Share The Lancet Neurology: November 16, 2010
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Lancet Neurology: November 16, 2010
Discussion of the RE-LY trial subgroup for the secondary prevention of stroke, and phase 2 results of gene therapy for Parkinson's disease.
View all episodes
By The Lancet NeurologyDiscussion of the RE-LY trial subgroup for the secondary prevention of stroke, and phase 2 results of gene therapy for Parkinson's disease.
More shows like In conversation with...
View all
Hidden Brain
43,643 Listeners
Neurology® Podcast
294 Listeners
Learning English Vocabulary
532 Listeners
Practical Neurology Podcast
51 Listeners
The Daily
112,376 Listeners
JAMA Medical News
88 Listeners
The Clinical Problem Solvers
514 Listeners
Neurology Exam Prep Podcast
181 Listeners
NEJM AI Grand Rounds
58 Listeners
Continuum Audio
79 Listeners
eanCast: Weekly Neurology
0 Listeners